03 Profile
Vital Signsby Bridgehead
Hansard to 12 November 2026 · 31,484 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Cancer
Munir Pirmohamed: no photograph is held, so the academic plate is shown instead.
Academic
Munir Pirmohamed
David Weatherall chair in medicine at the University of Liverpool, NHS chair of pharmacogenetics, and consultant physician at the Royal Liverpool University Hospital
Dec 2025Jan 2026FebMarAprMayJuneJulyAugSeptOctNovto date
2
Quoted in the press, across 2 topics since 20 Nov 2025
02 Quoted on · 2 of 29 topics
Munir Pirmohamed: key facts
- Kind of voice
- Academic
- Role
- David Weatherall chair in medicine at the University of Liverpool, NHS chair of pharmacogenetics, and consultant physician at the Royal Liverpool University Hospital
- Quoted on
- Cancer, Children's health
- Press coverage
- Quoted in the press
- Most recently quoted
- 14 Apr 2026
- First quoted
- 20 Nov 2025
04 On the record · press
What Munir Pirmohamed has said
By outlet · bar length shows relative volume
- pharmaceutical-journal.com
Where Munir Pirmohamed has been quoted
- Chemotherapy treatment altered for patients following genomics testing schemepharmaceutical-journal.com · 14 Apr 2026
- How can the NHS make the most of the paediatric pharmacogenomics opportunity?pharmaceutical-journal.com · 20 Nov 2025
How we found the articles that name Munir Pirmohamed: we searched news for these terms, by topic. Terms for 2 topics
Cancer
- cancer
- cancer treatment
- cancer screening
- cancer waiting times
- oncology
- chemotherapy
- radiotherapy
- cancer diagnosis
Also searched with “cancer” in each of 8 national papers, and in the Guardian by editor tag, and in trade press by category. Every term for Cancer
Children's health
- children's health
- paediatric
- child health
- children's hospital
- infant mortality
Also searched with “children's health” in each of 8 national papers, and in the Guardian by editor tag, and in trade press by category. Every term for Children's health
Verbatim
“It is great news for patients that the NHS was able to introduce the c.557A>G variant into the testing panel for DPYD based on our research findings. This is in keeping with the ten-year NHS plan to prevent serious adverse drug reactions through genomic testing. However, it is important to note that this is the beginning of the journey, rather than the end of the journey, as there many other variants in this gene, which need to be evaluated, and implemented into the testing panel.”
“Attendees at a roundtable hosted by The Pharmaceutical Journal discussed challenges around implementing pharmacogenomic prescribing in the NHS and particular considerations for paediatric patients.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.